News
GSK
42.87
-0.28%
-0.12
Weekly Report: what happened at GSK last week (0318-0322)?
Weekly Report · 3d ago
UK Stocks-Factors to watch on March 21
Britain's FTSE 100 index is seen opening higher on Thursday. Futures for the index are up 0.8%. Barclays is preparing to axe hundreds of jobs across its investment bank. EasyJet in talks with EU about taking over slots at Milan's Linate airport.
Reuters · 03/21 04:54
GSK to cap out-of-pocket inhaler costs in US
GSK to cap out-of-pocket costs at $35 per month for all its inhaled asthma and chronic lung disease medicines for eligible patients in the United States. British pharmaceutical giant follows similar moves by two of its rivals in the US. GSK to cap costs for inhaler costs in U.S.
Reuters · 03/20 20:50
Pfizer offloads $3.9 bln stake in Sensodyne-maker Haleon
Pfizer offloads $3.9 bln stake in Sensodyne-maker Haleon. Pfizer previously held a 32% stake, followed by second-largest shareholder GSK. Haleon said it would also repurchase 315 million pounds worth of shares from Pfizer.
Reuters · 03/19 08:19
UPDATE 2-AstraZeneca follows rival Boehringer in capping out-of-pocket costs for inhalers
AstraZeneca follows rival Boehringer in capping out-of-pocket costs for inhalers at $35 per month in the U.S. High drug prices in the United States have been the subject of growing political scrutiny. UK-based AstraZeneca's cap will apply to its respiratory products portfolio.
Reuters · 03/18 11:38
Weekly Report: what happened at GSK last week (0311-0315)?
Weekly Report · 03/18 09:12
UPDATE 1-Pfizer to cut stake in Sensodyne toothpaste-maker Haleon to 24%
Pfizer to cut stake in Sensodyne toothpaste-maker Haleon to about 24%. Pfizer currently holds a 32% stake in the company. Haleon makes household brands such as Sensodyn toothpaste and Advil painkillers. The company was spun out of British drugmaker GSK in July 2022.
Reuters · 03/18 07:15
Bird flu strain raises alarm as virus kills South American wildlife
Scientists say H5N1 bird flu virus has spread aggressively in wild birds and marine mammals in South America. The virus has already killed dolphins in Chile and Peru, and at least half a million birds regionwide. Two known cases in humans have been reported since the virus arrived in the continent in 2022. Scientists say the virus appears to be spreading between mammals.
Reuters · 03/13 10:00
Weekly Report: what happened at GSK last week (0304-0308)?
Weekly Report · 03/11 09:12
GSK PLC: Report of foreign issuer
Press release · 03/08 18:19
UPDATE 1-Boehringer to cap out-of-pocket inhaler cost at $35 per month
Boehringer Ingelheim to cap out-of-pocket costs for inhaler products for chronic lung disease and asthma at $35 per month starting June 1. German drugmaker says program will dramatically decrease costs at the pharmacy counter for patients. High healthcare costs in the United States are a grave concern for lawmakers.
Reuters · 03/07 12:29
Boehringer to cut out-of-pocket costs for inhalers to $35
Boehringer Ingelheim to cut out-of-pocket costs for inhalers to $35 per month starting June 1. The German drugmaker will reduce costs for the company's inhaler products for chronic lung disease and asthma. High healthcare costs in the United States are a grave concern for lawmakers and politicians.
Reuters · 03/07 11:00
UK Stocks-Factors to watch on March 6
Britain's FTSE 100 .FTSE index is seen opening lower on Wednesday. Futures for the index are down 0.22%. British finance minister expected to offer tax cuts to voters. WHO says resistance to GSK's HIV drug has exceeded levels observed in trials.
Reuters · 03/06 05:05
UK Stocks-Factors to watch on March 5
Britain's FTSE 100 index is seen opening lower on Tuesday. British consumer spending slid in February as bad weather kept shoppers at home. British stocks started the week on a downbeat note ahead of the budget later this week. FTSe futures are down 0.11%.
Reuters · 03/05 05:06
UPDATE 1-US urges court to preserve Obamacare mandate to cover cancer screenings, HIV drugs
US urges court to preserve Obamacare mandate to cover cancer screenings, HIV drugs. The mandate requires health insurers to cover preventive care services at extra cost to patients. A federal judge has blocked enforcement of the mandate. President Joe Biden's administration is asking the appeals court to overturn the ruling.
Reuters · 03/04 21:47
GSK's new HIV drug formula could support longer dosing intervals
GSK's HIV drug formula could support longer dosing intervals. The company has shifted its HIV focus to long-acting treatments and prevention therapies. Strong sales of medicines for HIV, the virus that causes AIDS, drove GSK's growth last year. GSK said a formulation of its HIV prevention and treatment drug could potentially be administered every four months.
Reuters · 03/04 18:45
BRIEF-GSK Says Data Show For First Time New Ultra Long-Acting Cabotegravir Formulation That Doubles Current Dosing Interval
GSK Says Data Show For First Time New Ultra Long-Acting Cabotegravir Formulation That Doubles Current Dosing Interval. GSK says data show for first time new ultra long-acting Cabote gravir formulation that doubles current dosing interval.
Reuters · 03/04 18:41
US court to weigh Obamacare mandate to cover HIV drug, cancer screenings
US court to weigh Obamacare mandate to cover HIV drug, cancer screenings. President Joe Biden's administration to urge appeals court to preserve the mandate. The mandate requires health insurers to cover preventive care services including HIV-preventing medication and cancer screenings at extra cost to patients. The preventive care mandate is part of the 2010 Affordable Care Act.
Reuters · 03/04 11:00
Weekly Report: what happened at GSK last week (0226-0301)?
Weekly Report · 03/04 09:12
EUROPE RESEARCH ROUNDUP-Heineken NV, Ferrari, IMCD NV
Analysts revise their ratings and price targets on several European companies. Heineken NV, Ferrari, IMCD NV and Segro among those with revised targets. BP, BMW and Asmi among companies with new ratings and targets revised on Monday. BP raises to overweight from equal weight; Ferrari downgraded to sell.
Reuters · 03/04 06:50
More
Webull provides a variety of real-time GSK stock news. You can receive the latest news about GSK PLC through multiple platforms. This information may help you make smarter investment decisions.
About GSK
GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. It has developed monoclonal antibodies to help treat different diseases. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with respiratory and inflammatory conditions. Its vaccine portfolio includes more than 20 vaccines that help to protect people from a range of diseases and infections, including meningitis, shingles and flu, among others. Its specialty medicines include medicines for immune-mediated conditions. Its specialty medicines are also engaged in developing medicines for respiratory disease and HIV. Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease, antibiotics, and medicines for skin diseases.